A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of VSA006 Injection in Chinese Adult Patients With Nonalcoholic Steatohepatitis (NASH)
Latest Information Update: 29 Mar 2024
At a glance
- Drugs GSK 4532990 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- Sponsors Visirna Therapeutics
Most Recent Events
- 29 Mar 2024 New trial record